[ad_1]
Source: aslysun / Shutterstock.com
Nukana (NASDAQ:NCNA) shares of the clinical-stage biopharmaceutical company have seen heavy trading this morning, leading to higher stock prices on Wednesday.
This means that as of this writing, more than 9.6 million shares of the company’s stock have been transferred. This is already significantly higher than the company’s average daily trading volume of about 407,000 shares.
Investors will note that this builds on Tuesday’s 16.5% rise in NCNA stock. Approximately 10.9 million shares were traded.
Investors will note that these gains come in tandem with the company’s new patent acquisitions. The title of this patent is “Phosphoramidate derivatives for use in the treatment of cancer.” This is especially true for treatments to which patients are resistant. ” This includes leukemia, prostate cancer, lung cancer, and breast cancer.
What you need to know about NCNA stock
It’s also worth mentioning that NCNA is a penny stock. This creates even more volatility, which is often even worse outside of normal trading hours.
It is possible that certain traders saw this news and became interested in NuCana, sending the stock higher today. If that’s true, investors will be wary of investing in NCNA. If the stock price falls from these highs, it can easily lead to losses.
NCNA stock was up 101.9% as of Wednesday morning.
Investors looking for more of the latest stock market stories are in luck!
All the latest stock market news traders need to know on Wednesdays. This includes the biggest stock movers before market this morning, as well as the latest relevant news. lee auto (NASDAQ:Lee) price reduction etc. All of this information is available at the links below.
More stock market news on Wednesday
About penny stocks and small stocks:With rare exceptions, InvestorPlace does not publish commentary on companies with a market capitalization of less than $100 million or with fewer than 100,000 shares traded daily. That’s because these “penny stocks” often become a playground for scammers and market manipulators. When publishing commentary about small-capitalization stocks that may be affected by our commentary, we require InvestorPlace.com writers to disclose this fact and alert readers to the risks.
read more:Penny stocks — How to make money without getting scammed
On the date of publication, William White did not have (directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer and are influenced by InvestorPlace.com. Publishing guidelines.
[ad_2]
Source link
